Novavax 96.4% effective against original variant of COVID
Health
- 12 March, 2021
- 06:26
The Novavax coronavirus vaccine proved 96.4 percent effective against the original variant of coronavirus and 86.3 percent effective against its British strain, Report informs, referring to RIA Novosti.
The third phase of the NVX CoV2373 vaccine trial took place in the UK. The study covered more than 15,000 participants aged 18-84, 27 percent of them were over 65.
The company also said that when it comes to severe form of COVID, the vaccine has demonstrated 100 percent effectiveness.
Latest News
21:32
Armenia, Bulgaria discuss implementation of TRIPP project
Foreign policy21:23
UAE not to allow use of its airspace, territory for attacks on Iran
Other countries21:11
UN Secretary-General issues serious warning over weakening of global legal system
Other countries21:00
French FM Barrot to visit Türkiye on Jan.27
Region20:50
Baku to host 2nd Educational Exhibition of Uzbek Universities
Education and science20:42
Kremlin confirms continuation of talks among Russia, US, and Ukraine
Other countries20:32
US, Armenia discuss implementation of TRIPP project
Foreign policy20:20
Slovakia opposes EU decision to phase out Russian gas imports
Other countries19:59